Effects of in Children with Allergen-Sensitized Atopic Dermatitis.

So Hyun Ahn, Wonsuck Yoon, So Young Lee, Hee Soon Shin, Mi Young Lim, Young Do Nam, Young Yoo

Journal: Journal of Korean medical science 2021;35(18):e128

PMID: 32383366

Abstract

[{"label":"BACKGROUND","text":"Recent studies have shown that oral administration of probiotics may improve the immune imbalance caused by dysbiosis of the gut microbiome in atopic dermatitis (AD). This study aimed to investigate the clinical and immunological effects of in children with mild to moderate AD."},{"label":"METHODS","text":"Children aged 2-13 years with AD were randomized to receive either 1.0 \u00d7 10 colony-forming units of or placebo, daily, for 12 weeks. The clinical severity of AD and transepidermal water loss were evaluated. Blood eosinophil counts, serum total immunoglobulin E (IgE), and cytokine levels were measured. The diversity and composition of the gut microbiota were also analyzed."},{"label":"RESULTS","text":"Eighty-two children were recruited, and 41 were assigned to the probiotics intervention group. The mean scoring of atopic dermatitis (SCORAD) indices at baseline were 30.4 and 34.3 for the probiotics and placebo groups, respectively. At week 12, the mean indices were 23.6 and 23.1 for the probiotics and placebo groups, respectively. Clinical severity decreased significantly over time in both groups, with no significant difference between the two groups. In both groups, there were no significant differences in cytokine levels, microbial diversity, or the relative abundance of the gut microbiota at week 12 compared with the corresponding baseline values. The mean subjective scores of SCORAD indices after intervention for the probiotics group were significantly lower than those for the placebo group in IgE sensitized AD ( = 0.019)."},{"label":"CONCLUSION","text":"Our results show improved symptoms in the probiotics and placebo groups, and we could not find additional effects of in AD. However, the mean subjective scores of SCORAD indices for the probiotics group are significantly improved compared with those for the placebo group in allergen-sensitized AD."},{"copyright":"\u00a9 2020 The Korean Academy of Medical Sciences."}]
Address: Department of Pediatrics, Korea University College of Medicine, Seoul, Korea.; Allergy Immunology Center, Korea University, Seoul, Korea.; Research Division of Food Functionality, Korea Food Research Institute, Wanju, Korea.; KFRI School, Korea University of Science and Technology, Wanju, Korea.; Allergy Immunology Center, Korea University, Seoul, Korea. [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.